Evidence map›Paper›PMID 12215897›Full record

ArticleGenes and immunity2002

Dominant NZB contributions to lupus in the (SWR x NZB)F1 model.

S Xie, S H Chang, P Sedrak, A Kaliyaperumal, S K Datta, C Mohan

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Looking back and looking forward.Genes and immunity · 2003
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

S XieSimmon's Arthritis Research Center and the Center for Immunology, University of Texas Southwestern Medical School, Dallas, TX 75390, USA.
S H Chang
P Sedrak
A Kaliyaperumal
S K Datta
C Mohan

Funding

Unconventional APC Inducing Autoimmune Th17 Cell Expansion in LupusR01AI041985 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DATTA, SYAMAL K · 1997 to 2014
$4.3M
IMPACT OF LUPUS SUSCEPTIBILITY LOCI ON B CELL TOLERANCER01AR044894 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI MOHAN, CHANDRA · 1998 to 2007
$2.1M
IMMUNOGENETIC AND CELLULAR ORIGINS OF NEPHROPHILIC ANASR01AI047460 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI MOHAN, CHANDRA · 1999 to 2003
$914k
NIAID NIH HHS AI41985NIAID NIH HHS AI47460NIAMS NIH HHS AR44894
6 · The paper itself

Abstract

(SWR x NZB)F1 (or SNF1) mice succumb to lupus nephritis. Analysis of NZB x SNF1 backcross mice has recently revealed the existence of four dominant SWR loci (H2 on Chr 17, Swrl-1 on Chr 1, Swrl-2 on Chr 14 and Swrl-3 on Chr 18), and two NZB loci (Nba1 and Lbw2/Sbw2, both on Chr 4) conferring lupus susceptibility. The present study focusing on a panel of 88 SWR x SNF1 backcross mice reveals the existence of five suggestive loci for antinuclear antibody formation, consisting of three dominant NZB contributions (Nba4 on Chr 5, Lbw4 on Chr 6, and Nba5 on Chr 7), and two recessive SWR contributions (Swrl-1 on Chr 1, and Swrl-4 on Chr 10). In addition, this study reveals a dominant NZB locus for GN (Nba3 on Chr 7, peak at 31 cM), and a dominant NZB locus linked to early mortality, on Chr 10 (peak at 4 cM). Collectively, these studies suggest that lupus in the SNF1 strain is the epistatic end-product of four dominant SWR loci and four dominant NZB loci. The immunological functions and molecular identities of these loci await elucidation.

Indexed as

Disease Models, AnimalGenes, DominantAnimalsAutoantibodiesChromosome MappingHybridization, GeneticImmunoglobulin GImmunoglobulin MLupus Erythematosus, SystemicMiceMice, Inbred NZBMicrosatellite RepeatsNephritisAutoantibodiesImmunoglobulin GImmunoglobulin M

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.